Quantcast
Home / News / Merck settles suit over illegal Vioxx marketing

Merck settles suit over illegal Vioxx marketing

Merck & Co. has agreed to pay at least $39 million into a fund to settle a Missouri class action over the marketing of the anti-inflammatory drug Vioxx, according to a tentative settlement agreement.